Similarly, MCC950 (an NLRP3 inhibitor) prevents ovarian endometriosis and the expression of NLRP3 and IL-1β in the endometrial stromal cells and cyst-derived stromal cells. Here, NLRP3 is linked to ovarian endometriosis.